J-pharma Co., Ltd.

This study is testing a new drug called nanvuranlat for people with advanced bile duct cancer that has worsened after one prior treatment. It will compare nanvuranlat against standard chemotherapy or supportive care to see which helps patients live longer. The trial aims to find …